378 related articles for article (PubMed ID: 12904354)
1. Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling.
Rogers GB; Hart CA; Mason JR; Hughes M; Walshaw MJ; Bruce KD
J Clin Microbiol; 2003 Aug; 41(8):3548-58. PubMed ID: 12904354
[TBL] [Abstract][Full Text] [Related]
2. characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling.
Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Bruce KD
J Clin Microbiol; 2004 Nov; 42(11):5176-83. PubMed ID: 15528712
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of Burkholderia species by PCR-restriction fragment length polymorphism analysis of the 16S rRNA gene and application to cystic fibrosis isolates.
Segonds C; Heulin T; Marty N; Chabanon G
J Clin Microbiol; 1999 Jul; 37(7):2201-8. PubMed ID: 10364586
[TBL] [Abstract][Full Text] [Related]
4. Bacterial activity in cystic fibrosis lung infections.
Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Kehagia V; Jones GR; Bruce KD
Respir Res; 2005 Jun; 6(1):49. PubMed ID: 15929792
[TBL] [Abstract][Full Text] [Related]
5. Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis.
Rogers GB; Carroll MP; Serisier DJ; Hockey PM; Jones G; Kehagia V; Connett GJ; Bruce KD
J Clin Microbiol; 2006 Jul; 44(7):2601-4. PubMed ID: 16825392
[TBL] [Abstract][Full Text] [Related]
6. Arbitrarily primed PCR and sequencing of 16S rDNA for epidemiological typing and species identification of Burkholderia cepacia isolates from Swedish patients with cystic fibrosis reveal genetic heterogeneity.
Karpati F; Giedraitis V; Thore M; Lindman R; Monstein HJ; Hjelte L; Jonasson J
APMIS; 2001 May; 109(5):389-400. PubMed ID: 11478687
[TBL] [Abstract][Full Text] [Related]
7. Modelling the bacterial communities associated with cystic fibrosis lung infections.
Spasenovski T; Carroll MP; Lilley AK; Payne MS; Bruce KD
Eur J Clin Microbiol Infect Dis; 2010 Mar; 29(3):319-28. PubMed ID: 20099020
[TBL] [Abstract][Full Text] [Related]
8. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.
van Belkum A; Renders NH; Smith S; Overbeek SE; Verbrugh HA
FEMS Immunol Med Microbiol; 2000 Jan; 27(1):51-7. PubMed ID: 10617790
[TBL] [Abstract][Full Text] [Related]
9. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
Kolak M; Karpati F; Monstein HJ; Jonasson J
Int J Med Microbiol; 2003 Aug; 293(4):309-17. PubMed ID: 14503795
[TBL] [Abstract][Full Text] [Related]
10. Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.
van Pelt C; Verduin CM; Goessens WH; Vos MC; Tümmler B; Segonds C; Reubsaet F; Verbrugh H; van Belkum A
J Clin Microbiol; 1999 Jul; 37(7):2158-64. PubMed ID: 10364579
[TBL] [Abstract][Full Text] [Related]
11. Polymerase chain reaction for the detection of Pseudomonas aeruginosa, Stenotrophomonas maltophilia and Burkholderia cepacia in sputum of patients with cystic fibrosis.
Karpati F; Jonasson J
Mol Cell Probes; 1996 Dec; 10(6):397-403. PubMed ID: 9025076
[TBL] [Abstract][Full Text] [Related]
12. Intragenomic and intraspecific heterogeneity of the 16S rRNA gene in seven bacterial species from the respiratory tract of cystic fibrosis patients assessed by PCR-Temporal Temperature Gel Electrophoresis.
Michon AL; Jumas-Bilak E; Imbert A; Aleyrangues L; Counil F; Chiron R; Marchandin H
Pathol Biol (Paris); 2012 Jun; 60(3):e30-5. PubMed ID: 21621347
[TBL] [Abstract][Full Text] [Related]
13. Combination of 16S rRNA variable regions provides a detailed analysis of bacterial community dynamics in the lungs of cystic fibrosis patients.
Doud MS; Light M; Gonzalez G; Narasimhan G; Mathee K
Hum Genomics; 2010 Feb; 4(3):147-69. PubMed ID: 20368138
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
Spasenovski T; Carroll MP; Payne MS; Bruce KD
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
[TBL] [Abstract][Full Text] [Related]
15. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
Botterel F; Angebault C; Cabaret O; Stressmann FA; Costa JM; Wallet F; Wallaert B; Bruce K; Delhaes L
Mycopathologia; 2018 Feb; 183(1):171-183. PubMed ID: 28766039
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.
Stressmann FA; Rogers GB; Klem ER; Lilley AK; Donaldson SH; Daniels TW; Carroll MP; Patel N; Forbes B; Boucher RC; Wolfgang MC; Bruce KD
J Clin Microbiol; 2011 Jan; 49(1):281-91. PubMed ID: 21068277
[TBL] [Abstract][Full Text] [Related]
17. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.
McDowell A; Mahenthiralingam E; Moore JE; Dunbar KE; Webb AK; Dodd ME; Martin SL; Millar BC; Scott CJ; Crowe M; Elborn JS
J Clin Microbiol; 2001 Dec; 39(12):4247-55. PubMed ID: 11724828
[TBL] [Abstract][Full Text] [Related]
18. Fourier transform infrared spectroscopy for rapid identification of nonfermenting gram-negative bacteria isolated from sputum samples from cystic fibrosis patients.
Bosch A; Miñán A; Vescina C; Degrossi J; Gatti B; Montanaro P; Messina M; Franco M; Vay C; Schmitt J; Naumann D; Yantorno O
J Clin Microbiol; 2008 Aug; 46(8):2535-46. PubMed ID: 18550747
[TBL] [Abstract][Full Text] [Related]
19. Development of a diagnostic PCR assay that targets a heat-shock protein gene (groES) for detection of Pseudomonas spp. in cystic fibrosis patients.
Clarke L; Moore JE; Millar BC; Garske L; Xu J; Heuzenroeder MW; Crowe M; Elborn JS
J Med Microbiol; 2003 Sep; 52(Pt 9):759-763. PubMed ID: 12909651
[TBL] [Abstract][Full Text] [Related]
20. Restriction fragment-length polymorphism analysis of 16S rDNA from oral asaccharolytic Eubacterium species amplified by polymerase chain reaction.
Sato T; Sato M; Matsuyama J; Kalfas S; Sundqvist G; Hoshino E
Oral Microbiol Immunol; 1998 Feb; 13(1):23-9. PubMed ID: 9573818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
